Aerogen opens India headquarters to expand access to aerosol drug delivery solutions
Company establishes presence in New Delhi to support respiratory care advancements
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
FOPE & PharmaState Academy conducts session 17 on gap analysis and implementation plan for…
A structured and well-documented Gap Analysis is essential for identifying deficiencies, strengthening compliance, and ensuring…
Supriya Lifescience expands solar power capacity with 5 MWp facility in Maharashtra
Company strengthens renewable energy commitment with latest solar project
USV launches Xenia: Empagliflozin and its combinations for diabetes care in India
With the loss of exclusivity, Empagliflozin and its combinations are now available at one-fifth the cost, enhancing affordability
Cipla, Formosa sign multi-regional licensing deal for Clobetasol Suspension
This partnership aims to enhance ophthalmic care by providing treatment for post- operative inflammation and pain in patients…
Shilpa Biologicals partners with mAbTree Biologics for novel immuno-oncology asset
Shilpa to undertake both development and commercial supply for mAbTree’s novel checkpoint inhibitor
Lupin gains tentative USFDA approval for Amifampridine Tablets
Amifampridine Tablets, 10 mg, are bioequivalent to Firdapse Tablets, 10 mg of Catalyst Pharmaceuticals
Peptris Technologies out-licenses AI-discovered drug candidate to Revio Therapeutics
Under the agreement, Revio Therapeutics will hold commercialisation rights to PEPR124 (RT001) in all markets except in BRICS…
AstraZeneca to acquire EsoBiotec to advance cell therapy ambition
EsoBiotec will become a wholly owned subsidiary of AstraZeneca, with operations in Belgium
Zydus receives final USFDA approval for Eluxadoline Tablets, 75 mg and 100 mg
Eluxadoline is a mu-opioid receptor agonist, indicated in adults for the treatment of irritable bowel syndrome with diarrhoea…
AI-driven drug discovery, precision medicine, and sustainable manufacturing can redefine the pharma…
Ramandeep Singh, Vice President, Life Sciences and Healthcare, India, Clarivate, discusses the latest innovative R&D,…
IA-2A positivity could help develop effective intervention strategies in type 1 diabetes…
IA-2A identified as a key biomarker for type 1 diabetes risk stratification and early intervention strategies
H.E.L Group and ICT Mumbai sign research agreement to enhance process safety in chemical synthesis
H.E.L Group to provide simular reaction Calorimeter to ICT Mumbai for process safety research and education
Tenthpin Management Consultants launches AI labs in Hyderabad to drive life sciences Innovation
Global consulting firm Tenthpin establishes AI-focused Centre of Excellence in Hyderabad to accelerate AI adoption in Life…
IPA questions FAERS data interpretation in the Ohio State University study
The Indian Pharmaceutical Alliance (IPA) states that a higher rate of serious adverse events (SAEs) for drugs manufactured in…
Zydus Lifesciences receives USFDA approval for Methenamine Hippurate tablets
Approval allows Zydus to manufacture and market 1-gram Methenamine Hippurate tablets in the United States
Davaindia expands in Kerala to improve access to affordable generic medicines
With over 50 stores in Kerala, Davaindia aims to expand further into Tier 2 and rural areas while promoting awareness of generic…
Alkem Laboratories launches generic Empagliflozin in India at reduced cost
Empanorm and its combinations introduced at prices approximately 80 per cent lower than innovator products
Sun Pharma to acquire Checkpoint Therapeutics in oncology deal
Transaction to expand Sun Pharma’s onco-derm portfolio with FDA-approved treatment for advanced cSCC
Glenmark USA launches Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful (OTC)
It compares to the active ingredient in MiraLAX Powder for Solution, 17 grams of Bayer HealthCare